Jump to content

Hyperinsulinemia

From Wikipedia, the free encyclopedia
Hyperinsulinemia
Other namesHyperinsulinaemia
Insulin binding to its receptor
SpecialtyEndocrinology Edit this on Wikidata

Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose. While it is often mistaken for diabetes or hyperglycaemia, hyperinsulinemia can result from a variety of metabolic diseases and conditions, as well as non-nutritive sugars in the diet.[1] [better source needed] While hyperinsulinemia is often seen in people with early stage type 2 diabetes mellitus, it is not the cause of the condition and is only one symptom of the disease [citation needed] (for opposing view see review in [2]). Type 1 diabetes only occurs when pancreatic beta-cell function is impaired. Hyperinsulinemia can be seen in a variety of conditions including diabetes mellitus type 2, in neonates and in drug-induced hyperinsulinemia. It can also occur in congenital hyperinsulinism, including nesidioblastosis.

Hyperinsulinemia is associated with hypertension, obesity, dyslipidemia, insulin resistance, and glucose intolerance.[3] These conditions are collectively known as metabolic syndrome.[4] This close association between hyperinsulinemia and conditions of metabolic syndrome suggest related or common mechanisms of pathogenicity.[3] Hyperinsulinemia has been shown to "play a role in obese hypertension by increasing renal sodium retention".[3]

In type 2 diabetes, the cells of the body become resistant to the effects of insulin as the receptors which bind to the hormone become less sensitive to insulin concentrations resulting in hyperinsulinemia and disturbances in insulin release.[5] With a reduced response to insulin, the beta cells of the pancreas secrete increasing amounts of insulin in response to the continued high blood glucose levels resulting in hyperinsulinemia. In insulin resistant tissues, a threshold concentration of insulin is reached causing the cells to uptake glucose and therefore decreases blood glucose levels. Studies have shown that the high levels of insulin resulting from insulin resistance might enhance insulin resistance.[5]

Studies on mice with genetically reduced circulating insulin suggest that hyperinsulinemia plays a causal role in high fat diet-induced obesity. In this study, mice with reduced insulin levels expended more energy and had fat cells that were reprogrammed to burn some energy as heat.[6]

Hyperinsulinemia in neonates can be the result of a variety of environmental and genetic factors. If the mother of the infant is a diabetic and is not able to properly control her blood glucose levels, the hyperglycemic maternal blood can create a hyperglycemic environment in the fetus. To compensate for the increased blood glucose levels, fetal pancreatic beta cells can undergo hyperplasia. The rapid division of beta cells results in increased levels of insulin being secreted to compensate for the high blood glucose levels. Following birth, the hyperglycemic maternal blood is no longer accessible to the neonate resulting in a rapid drop in the newborn's blood glucose levels. As insulin levels are still elevated this may result in hypoglycemia. To treat the condition, high concentration doses of glucose are given to the neonate as required maintaining normal blood glucose levels. The hyperinsulinemia condition subsides after one to two days.[7]

Symptoms and signs

[edit]

A large abdomen is a strong indicator of Hyperinsulinemia, so measure waist to hip ratio. But the best way to know if you have hyperinsulinemia is to get insulin levels checked. It is important to note that in some people Insulin can be elevated in the presence of normal glucose for 10-20 years, so it is best not to rely on glucose levels without also measuring insulin [citation needed]

Some patients may experience a variety of symptoms when hypoglycemia is present, including:[8]

If a person experiences any of these symptoms, a visit to a qualified medical practitioner is advised, and diagnostic blood testing, such as Fasting Insulin Levels, may be required.[citation needed]

Causes

[edit]

Possible causes include:[citation needed]

[edit]

Often, individuals get metabolically (internally) sick before showing signs of obesity. But visceral obesity can go undetected, and is extremely dangerous. Lifestyle choices including diet, exercise, and sleep deprivation play the largest role in Hyperinsulinemia & insulin resistance.[citation needed]

Belly fat is a strong predictor of high insulin levels. Obesity is characterized by an excess of adipose tissue – insulin increases the synthesis of fatty acids from glucose, facilitates the entry of glucose into adipocytes and inhibits breakdown of fat in adipocytes.[11]

On the other hand, adipose tissue is known to secrete various metabolites, hormones and cytokines that may play a role in causing hyperinsulinemia.[12] Specifically cytokines secreted by adipose tissue directly affect the insulin signalling cascade, and thus insulin secretion.[13] Adiponectins are cytokines that are inversely related to percent body fat; that is people with a low body fat will have higher concentrations of adiponectins where as people with high body fat will have lower concentrations of adiponectins. In 2011, it was reported that hyperinsulinemia is strongly associated with low adiponectin concentrations in obese people, though whether low adiponectin has a causal role in hyperinsulinemia remains to be established.[13]

Diagnosis

[edit]

Fasting Insulin levels in blood may be measured as this can be elevated in the presence of normal glucose. Diagnosis is often made by checking normal levels of glucose that exceed 1.7 mmol/L (30 mg/dL) when 1 mg of glucagon is administered IM or IV.[16] In addition, urine samples or blood samples are also used to check levels of ketones and low free fatty acids.[17]

After diagnosis, most people are required to continue regular check ups for evaluations.[17]

Differential diagnosis

[edit]
  • Hyperinsulinemia is often mistaken for diabetes or hypoglycaemia. These are separate, albeit related, conditions. Adipocytes will generate triglycerides in the presence of insulin [18] but refers to a liver condition rather than a pancreatic one.

Treatment

[edit]

Treatment is typically achieved via diet and exercise, although metformin may be used to reduce insulin levels in some patients (typically where obesity is present). A referral to a dietician is beneficial. Another method used to lower excessively high insulin levels is cinnamon, specifically Ceylon cinnamon,[19] as was demonstrated when supplemented in clinical human trials.[20]

A healthy diet that is low in simple sugars and processed carbohydrates, and high in fiber, and vegetable protein is often recommended. This includes replacing white bread with whole-grain bread, reducing intake of foods composed primarily of starch such as potatoes, and increasing intake of legumes and green vegetables, particularly soy.[21]

Regular monitoring of weight, blood sugar, and insulin are advised, as hyperinsulinemia may develop into diabetes mellitus type 2.[22]

It has been shown in many studies that physical exercise improves insulin sensitivity.[23] The mechanism of exercise on improving insulin sensitivity is not well understood however it is thought that exercise causes the glucose receptor GLUT4 to translocate to the membrane.[24] As more GLUT4 receptors are present on the membrane more glucose is taken up into cells decreasing blood glucose levels which then causes decreased insulin secretion and some alleviation of hyperinsulinemia.[23] Another proposed mechanism of improved insulin sensitivity by exercise is through AMPK activity.[23] The beneficial effect of exercise on hyperinsulinemia was shown in a study in 2009, where they found that improving fitness through exercise significantly decreases blood insulin concentrations.[23] Moreover, a diet that consists of high amounts of carbs have been linked to weight gain and obesity in rodents. Although this has not been tested in humans, it is assumed that it could aid with the prevention of weight gain in humans, and possibly obesity.[25] Medications have also been studied to treat hyperinsulinemia, although these might have some side effects, these could be used as an alternative.[26]

See also

[edit]

References

[edit]
  1. ^ Ballantyne, Sarah, "Is It Paleo? Splenda, Erythritol, Stevia, and Other Low-Calorie Sweeteners", 03 Jan 2015, https://www.thepaleomom.com/paleo-splenda-erythritol-stevia-low-calorie-sweeteners/ (last accessed 02 Sept 2020).
  2. ^ Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick, Jesse Roth; Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?. Diabetes Care 1 February 2008; 31 (Supplement_2): S262–S268. https://doi.org/10.2337/dc08-s264
  3. ^ a b c Modan, Michaela; Halkin H; Almog S; Lusky A; Eshkol A; Shefi M; Shitrit A; Fuchs Z (March 1985). "Hyperinsulinemia: A link between hypertension obesity and glucose intolerance". J. Clin. Invest. 75 (3): 809–17. doi:10.1172/JCI111776. PMC 423608. PMID 3884667.
  4. ^ Danker, Rache; Chetrit A; Shanik MH; Raz I; Roth J (August 2009). "Basal-stat hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up". Diabetes Care. 32 (8): 1464–66. doi:10.2337/dc09-0153. PMC 2713622. PMID 19435961.
  5. ^ a b Shanik, M.H.; Yuping, X.; Skrha, J.; Danker, R.; Zick, Y.; Roth, J. (2008). "Insulin Resistance and Hyperinsulinemia". Diabetes Care. 31 (2): S262–68. doi:10.2337/dc08-s264. PMID 18227495.
  6. ^ Arya E. Mehran; Nicole M. Templeman; G. Stefano Brigidi; Gareth E. Lim; Kwan-Yi Chu; Xiaoke Hu; Jose Diego Botezelli; Ali Asadi; Bradford G. Hoffman; Timothy J. Kieffer; Shernaz X. Bamji; Susanne M. Clee; James D. Johnson (6 Dec 2012). "Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production". Cell Metabolism. 16 (5): 723–37. doi:10.1016/j.cmet.2012.10.019. PMID 23217255.
  7. ^ Ferry, R.J. (2010). Hyperinsulinism "Medscape".
  8. ^ "Hyperinsulinemia means that the amount of insulin in the blood is higher than considered normal amongst non-diabetics". January 15, 2019.
  9. ^ Stout RW (1996). "Hyperinsulinemia and atherosclerosis". Diabetes. 45 (Suppl 3): S45-6. doi:10.2337/diab.45.3.s45. PMID 8674889.
  10. ^ Clément L, Poirier H, Niot I, Bocher V, Guerre-Millo M, Krief S, Staels B, Besnard P (2002). "mice fed a diet enriched in t10,c12-CLA (0.4% w/w) for 4 weeks developed lipoatrophy, hyperinsulinemia, and fatty liver, whereas diets enriched in c9,t11-CLA and LA had no significant effect ; from google (hyperinsulinemia trans fat) result 2". J Lipid Res. 43 (9): 1400–09. doi:10.1194/jlr.M20008-JLR200. PMID 12235171.
  11. ^ "Physiologic Effects of Insulin". Archived from the original on 2016-11-19. Retrieved 2016-11-03.
  12. ^ Matsuzawa, Y; Fanahashi T; Nakamura T (1999). "Moleculare mechanism of metabolic syndrome X: contribution of adiposcyte-derived bioactive substances". Annals of the New York Academy of Sciences. 892 (1): 146–54. Bibcode:1999NYASA.892..146M. doi:10.1111/j.1749-6632.1999.tb07793.x. PMID 10842660. S2CID 22802586.
  13. ^ a b Weyer, C; Funahachi T; Tanaka S; Hotta K; Matsuzawa Y; Pratley RE; Tataranni PA (2011). "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia". The Journal of Clinical Endocrinology & Metabolism. 86 (5): 1930–35. doi:10.1210/jcem.86.5.7463. PMID 11344187.
  14. ^ Poloz, Y.; Stambolic, V. (2015). "Obesity and cancer, a case for insulin signaling". Cell Death and Disease. 6 (12): e2037. doi:10.1038/cddis.2015.381. PMC 4720912. PMID 26720346.
  15. ^ Vigneri, R.; Goldfine, I. D.; Frittitta, L. (2016). "Insulin, insulin receptors, and cancer". Journal of Endocrinological Investigation. 39 (12): 1365–1376. doi:10.1007/s40618-016-0508-7. PMID 27368923. S2CID 46524730.
  16. ^ Arnoux, Jean-Baptiste; Verkarre, Virginie; Saint-Martin, Cécile; Montravers, Françoise; Brassier, Anaïs; Valayannopoulos, Vassili; Brunelle, Francis; Fournet, Jean-Christophe; Robert, Jean-Jacques; Aigrain, Yves; Bellanné-Chantelot, Christine; de Lonlay, Pascale (3 October 2011). "Congenital hyperinsulinism: current trends in diagnosis and therapy". Orphanet Journal of Rare Diseases. 6: 63. doi:10.1186/1750-1172-6-63. PMC 3199232. PMID 21967988.
  17. ^ a b Arnoux, Jean-Baptiste; Verkarre, Virginie; Saint-Martin, Cécile; Montravers, Françoise; Brassier, Anaïs; Valayannopoulos, Vassili; Brunelle, Francis; Fournet, Jean-Christophe; Robert, Jean-Jacques; Aigrain, Yves; Bellanné-Chantelot, Christine (2011-10-03). "Congenital hyperinsulinism: current trends in diagnosis and therapy". Orphanet Journal of Rare Diseases. 6 (1): 63. doi:10.1186/1750-1172-6-63. ISSN 1750-1172. PMC 3199232. PMID 21967988.
  18. ^ "Physiologic Effects of Insulin". www.vivo.colostate.edu. Archived from the original on 2023-05-07. Retrieved 2020-09-05.
  19. ^ Hayward, Nicholas J.; McDougall, Gordon J.; Farag, Sara; Allwood, J. William; Austin, Ceri; Campbell, Fiona; Horgan, Graham; Ranawana, Viren (2019). "Cinnamon Shows Antidiabetic Properties that Are Species-Specific: Effects on Enzyme Activity Inhibition and Starch Digestion". Plant Foods for Human Nutrition. 74: 544–552.
  20. ^ Solomon, TP; Blannin, AK (November 2007). "Effects of short-term cinnamon ingestion on in vivo glucose tolerance". Diabetes, Obesity & Metabolism. 9 (6): 895–901. doi:10.1111/j.1463-1326.2006.00694.x. PMID 17924872. S2CID 10443919.
  21. ^ Villegas, R; Gao, YT; Yang, G; Li, HL; Elasy, TA; Zheng, W; Shu, XO (January 2008). "Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study". The American Journal of Clinical Nutrition. 87 (1): 162–7. doi:10.1093/ajcn/87.1.162. PMC 2361384. PMID 18175751.
  22. ^ Weyer, C.; Hanson, R. L.; Tataranni, P. A.; Bogardus, C.; Pratley, R. E. (2000-12-01). "A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia". Diabetes. 49 (12): 2094–2101. doi:10.2337/diabetes.49.12.2094. ISSN 0012-1797. PMID 11118012.
  23. ^ a b c d Solomon, Thomas P; Haus JM; Kelly KR; Cook MD; Riccardi M; Rocco M; Kashyap SR; Barkowkis H; Kirwan JP (2009). "Randomized trial on the effects of a 7-d low-glycemic diet and exercise intervention on insulin resistance in older obese humans". Am J Clin Nutr. 90 (5): 1222–29. doi:10.3945/ajcn.2009.28293. PMC 2762157. PMID 19793849.
  24. ^ Lund, S; Holman GD; Schmitz O; Pedersen O (1995). "Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin". Proc. Natl. Acad. Sci. U.S.A. 92 (13): 5817–5821. Bibcode:1995PNAS...92.5817L. doi:10.1073/pnas.92.13.5817. PMC 41592. PMID 7597034.
  25. ^ Erion, Karel A.; Corkey, Barbara E. (June 2017). "Hyperinsulinemia: a Cause of Obesity?". Current Obesity Reports. 6 (2): 178–186. doi:10.1007/s13679-017-0261-z. ISSN 2162-4968. PMC 5487935. PMID 28466412.
  26. ^ Demirbilek, Hüseyin; Hussain, Khalid (2017-12-30). "Congenital Hyperinsulinism: Diagnosis and Treatment Update". Journal of Clinical Research in Pediatric Endocrinology. 9 (Suppl 2): 69–87. doi:10.4274/jcrpe.2017.S007. ISSN 1308-5735. PMC 5790328. PMID 29280746.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Hyperinsulinemia&oldid=1242568795"